OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	314
Extracutaneous sporotrichosis	270
Transmission of Infections during Cardiopulmonary Resuscitation	170
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	169
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	157
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	134
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	127
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	127
Progression of antibiotic resistance in Neisseria meningitidis	126
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	106
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	106
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	101
Viral infections and pathogenesis of glaucoma: a comprehensive review	91
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	90
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	89
Review of BCG immunotherapy for bladder cancer	85
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	84
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	78
Viral Respiratory Pathogens and Lung Injury	76
Evolutionary Pathways and Trajectories in Antibiotic Resistance	73
Congenital Syphilis: a Review of Global Epidemiology	69
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	65
Neisseria gonorrhoeae vaccines: a contemporary overview	62
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	62
BCG therapy in bladder cancer and its tumor microenvironment interactions	58

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	58
Diagnosis, Management, and Future Control of Cholera	55
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	54
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	53
Aspergillus terreus Species Complex	52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	52
Trained Immunity as a Preventive Measure for Surgical Site Infections	50
Harnessing the host response for precision infectious disease diagnosis	48
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	47
Agnostic Sequencing for Detection of Viral Pathogens	45
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	45
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	45
Artemisinin-resistant malaria	44
Advances in the Microbiology of Stenotrophomonas maltophilia	43
Editorial Board	42
Editorial Board	41
2021 Acknowledgment of CMR Reviewers	40
The challenges of difficult-to-treat Acinetobacter infections	40
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future	40
COVID-19 therapeutics	39
Pneumocystis jirovecii pneumonia in people living with HIV: a review	38
Pathogenesis of viral infections during pregnancy	37
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing	36
Editorial Board	34
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response	34
Editorial Board	32
Natural-Product-Based Solutions for Tropical Infectious Diseases	32
SARS-CoV-2 Antiviral Therapy	32
Invasive fusariosis	31
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	31
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	31
Updated Review onNocardiaSpecies: 2006–2021	29
Laboratory Detection of Malaria Antigens: a Strong Tool for Malaria Research, Diagnosis, and Epidemiology	28
Osteoarticular Mycoses	28
Clinical Microbiology Reviews : a 21st century vision	27
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	27
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	27
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream	26
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities	26
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use	25
Surveillance and prevention of infection in clinical xenotransplantation	23
Host Immunity and Immunization Strategies for Clostridioides difficile Infection	23
Current perspectives in the epidemiology and control of lymphatic filariasis	22
Masks and respirators for prevention of respiratory infections: a state of the science review	21
Advancements and challenges in antifungal therapeutic development	20
A call for the United States to continue investing in science	19
Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health	18
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”	17
Neurological complications caused by SARS-CoV-2	17
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections	17

Human Listeriosis	17
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	16
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	16
2023 Acknowledgment of CMR Reviewers	16
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis	16
Monkeypox Virus Infections in Humans	15
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials	15
2024 Acknowledgment of CMR Reviewers	15
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	14
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management	13
Recent advances in therapeutic probiotics: insights from human trials	13
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations	12
Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections	12
Laboratory detection of carbapenemases among Gram-negative organisms	12
Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments	12
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review	12